Mateus Crespo

9PUBLICATIONS
134CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 30, 2026
IAP antagonist tolinapant (ASTX660) in combination with pembrolizumab in advanced solid tumors: a phase I trial.

|Apr 27, 2026
Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma.

|Oct 08, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

|Jan 09, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Jonathan Welti, Denisa Bogdan, Ines Figueiredo

|Feb 27, 2024
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer.

Antje Neeb, Ines Figueiredo, Denisa Bogdan

|Oct 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.

Christina Guo, Adam Sharp, Bora Gurel

Pageof 2

Frequent Collaborators

8 joint publications

Bora Gurel

8 joint publications

Johann S de Bono

6 joint publications

Suzanne Carreira

5 joint publications

Susana Miranda